Zugl.: Kiel, Universiẗat, Diss., 2009.

Zugl.: Berlin, Freie Univ., Diss., 2005 / Dateiformat: zip, Dateien im PDF-Format

Freie Universiẗat, Diss., 2005--Berlin. / Dateiformat: zip, Dateien im PDF-Format.

The objectives were to: 1) determine if im treatments of Lutalyse expedited the training of sexually inexperienced boars for semen collection and increased spermatozoal output, and 2) determine the effects of dietary L-carnitine supplementation on boar libido, semen quality, sperm production, and maintenance of sperm motility during liquid storage. Experiment 1 utilized lean-type, terminal-line boars (National Pig Development, Roanoke Rapids, NC) (n = 40; 177.4 ± 2.4 d of age and 112.8 ± 2.0 kg body weight) that had not previously experienced natural mating. Boars were individually moved twice weekly for 6 weeks (total of 12 training sessions) to a semen collection room equipped with an artificial sow. Upon entering the semen collection room, boars received in treatments of either deionized water (4 mL, n = 10) or Lutalyse at doses of 5 mg (n = 10), 10 mg (n = 10), or 20 mg (n = 10), and subsequently received a libido score of 1 to 5 (1 = no interest in the artificial sow; 5 = mounting the artificial sow and allowing semen collection). The percentages of boars successfully trained for semen collection during the experimental period were similar (P > 0.05) for controls (20%) and boars receiving 5 mg (30%), 10 mg (20%), or 20 mg (10%) of Lutalyse. Average libido score for boars receiving 10 mg Lutalyse (2.35 ± 0.08) was greater (P < 0.05) than for controls (2.14 ± 0.06). Libido score for the 20 mg treatment group were (1.78 ± 0.06) lower (P < 0.05) compared to the other treatment groups. Characteristics of ejaculates (volume, gel weight, sperm concentration, total spermatozoa) from control boars and boars treated with Lutalyse at doses of 5, 10, or 20 mg were similar (P > 0.05). For Exp. 2, the same group of boars was utilized in two similar trials (Trial 1, 1a, 1b: n = 9 for control and L-carnitine-treated boars; Trial 2, 2a, 2b: n = 10 for control and L-carnitine-treated boars). Boars were fed a fortified, corn and soybean meal-based diet at a rate of 2 kg/d. Boars that were randomly selected for L-carnitine treatment received the same diet mixed with L-carnitine to achieve supplementation of 500 mg/d. For 16 wk, semen was collected weekly via the gloved hand method and was analyzed for gel-free volume, gel weight, sperm concentration, sperm per ejaculate, and characteristics of sperm motility. Time to ejaculation (reaction time), duration of ejaculation, and number of false mounts were also recorded for each collection. Trials 1a and 2a were conducted during weeks 16 and 17 for each respective trial. Boars were collected once on 4 consecutive days, allowed 4 d of rest, and then collected again, to estimate daily spermatozoal production. At the end of 16 wk, a semen sample was also processed and extended in Beltsville Thawing Solution (BTS) to achieve a dilution of 3 x 109 spermatozoa/100 mL-dose for Trials 1b and 2b. The extended semen was stored in plastic bottles at 18°C and motility was evaluated daily for 7 d post collection. L-carnitine supplementation for 16 wk had no effects on semen volume, gel weight, total number of sperm cells per ejaculate, reaction time, or sperm motility (P > 0.1). Boars receiving the L-carnitine-supplemented diet displayed an increase in the number of false mounts before ejaculating and an increase in sperm concentration (P < 0.05) in Trial 2. A treatment by week interaction was detected for sperm concentration in Trial 2 (P < 0.005). Increased sperm concentrations in L-carnitine-treated boars were demonstrated after only one week of feeding the respective diets. Given that the production of a mature sperm cell requires 7 to 8 wk in boars, it is therefore difficult to conclude that differences in sperm concentration were due solely to treatment. Daily spermatozoal production was similar between control boars and boars supplemented with L-carnitine (P > 0.1) for both Trials 1a and 2a. L-carnitine supplementation did not affect percent motility in Trials 1b and 2b or sperm progressive motility in Trial 2b during 7 d storage (P > 0.1). A treatment by day interaction was determined for sperm velocity (P < 0.05) in Trial 2b. L-carnitine supplementation decreased mean sperm velocity significantly after 2 d of storage. Overall, L-carnitine had no beneficial effects on boar libido, semen quality, sperm production, or maintenance of sperm motility during liquid storage. However, Lutalyse increased libido scores, but did not affect the number of boars trained for semen collection or number of spermatozoa ejaculated. / Master of Science

Incidences of uterine infections in dairy cattle are high between parturition and Day 21 postpartum. Dairy cows with uterine infections are at risk for prolonged periods of days open and multiple services before becoming pregnant. Neutrophils are the first wave of immune system defense against uterine contamination. Neutrophil function seems to be mediated by reproductive hormones and good uterine health is related to properly functioning neutrophils. To elucidate the interaction between reproductive hormones, neutrophils and uterine health in dairy cows the objectives of this research were to evaluate: 1) changes in circulating white blood cell populations during the estrous cycle, 2) the effects of prostaglandin F₂[subscript α](PGF₂[subscript α]) on circulating white blood cell populations and 3) the effects of a two-injection PGF₂[subscript α] regimen on uterine neutrophil and bacterial populations and numbers of days open and services per conception. In the first experiment, the effect of stage of the estrous cycle on plasma neutrophil numbers was evaluated. Neutrophils were observed throughout the entire estrous cycle and numbers were greatest (P<0.05) on Day 14 (mid-cycle), when the corpus luteum was the dominant ovarian structure and plasma progesterone was at its acme. In the second experiment, plasma neutrophil numbers were examined in cows after injections of saline or the PGF₂[subscript α] pharmaceutical product, Lutalyse. Compared to saline, numbers of neutrophils were greater (P<0.05) 4 and 8 hr after Lutalyse injection. In the third experiment, neutrophil numbers were examined after injections of saline, Lutalyse or the PGF₂[subscript α] analog, Estrumate. Compared to saline, numbers of neutrophils did not differ (P>0.10) from cows injected with Lutalyse or Estrumate. In the fourth experiment, uterine bacterial populations and numbers of neutrophils were quantified in cows treated with Lutalyse or saline on Days 0 and 14 or 14 and 28 postpartum. Compared to saline, Lutalyse treatment decreased (P<0.05) total bacteria present in the uterus and increased (P<0.05) the number of uterine neutrophils. In experiment five, numbers of days open and services per conception were evaluated in cows treated with Lutalyse or saline on Days 0 and 14 or 14 and 28 postpartum. Compared to saline, Lutalyse decreased days open (154.7 ± 14.1 vs. 120.1 ± 7.9 days, respectively; P<0.05) and services per conception (3.0 ± 0.4 vs. 2.3 ± 0.2 services, respectively; P=0.09). These results suggest PGF₂[subscript α] treatment can increase neutrophil and depress bacterial cell populations in favor of the dairy cow's uterine health and may explain why fertility is improved when PGF₂α is administered early in the postpartum period. / Graduation date: 2012

No description available.

Heterocyclic amino acids can serve as tools in structure-activity relationship (SAR) studies. They can also act as peptide secondary structure initiators. Incorporation of heterocyclic amino acid units into peptides can limit flexibility, improve receptor binding affinity, enhance selectivity, and augment potency. Among heterocyclic amino acids, substituted prolines, alpha-amino-delta-lactams, and indolizidine-2-one amino acid derivatives have shown significant utility; however, their syntheses remain challenging. Various unsaturated amino acids have previously been synthesized using copper catalyzed SN2’ reactions of the zincate from beta-iodoalanine derivatives onto allylic halides, such as (Z)-1,4-dichlorobut-2-ene, 3-chloro-2-(chloromethyl)prop-1-ene, and (E)-1,3-dichloroprop-1-ene. Employing the resulting olefins as building block, a variety of substituted heterocyclic amino acids have now been prepared by routes featuring halide displacements and olefin oxidation. For example, 2-N-(Boc)amino-4-(chloromethyl)hexenoate was employed in halide displacements to synthesize 4-vinylproline (4-Vyp), 4-vinylornithine (4-Von) and gamma-vinyl-alpha-amino-delta-lactams. Moreover, unsaturated diamino azelates were employed to synthesize 6-hydroxymethyl and 5- and 7-hydroxy indolizidine-2-one amino acid (I2aa) derivatives by routes featuring olefin oxidation. X-ray studies have demonstrated that 6-hydroxymethyl and 7-hydroxy I2aa residues can mimic the backbone geometry of the central residues of ideal type II’ beta-turns. Replacement of the I2aa residue of a potent prostaglandin-F2α (PGF2alpha) receptor (FP) modulator by the 5-, 6- and 7-substituted counterparts was performed to study the influences of substituents and backbone geometry on inhibitory effects on myometrial contractility in mouse models. A promising gateway for preparing different heterocyclic amino acids has been opened by employing unsaturated amino acid building blocks. In these routes, the olefin has served as a means for adding functional group diversity onto the ring systems. Access to a variety of substituted ring systems has expanded the toolbox for studying peptide structures using substituted heterocyclic amino acids. / Les acides aminés hétérocycliques peuvent servir d'outils dans les études des relations structure-activité (RSA). Ils peuvent également jouer le rôle d'initiateurs de structure secondaire peptidique. L'incorporation d'unités d'acides aminés hétérocycliques dans des peptides peut limiter la flexibilité, améliorer l'affinité de liaison au récepteur, améliorer la sélectivité et augmenter l’activité. Parmi les acides aminés hétérocycliques, les prolines substituées, les alpha-amino-delta-lactames et les dérivés d'acides aminés indolizidine-2-one ont montré une utilité significative. Cependant, leurs synthèses restent difficiles. Divers acides aminés insaturés ont déjà été synthétisés à l'aide de réactions SN2' catalysées par le cuivre de zincate à partir de dérivés de beta-iodoalanine sur des halogénures allyliques, tels que le (Z)-1,4-dichlorobut-2-ène, le 3-chloro-2-(chlorométhyl)prop-1-ène et (E)-1,3-dichloroprop-1-ène. En utilisant les oléfines résultantes comme synthons, une variété d'acides aminés hétérocycliques substitués ont maintenant été préparés via les déplacements d'halogénures et oxydations d’oléfines. Par exemple, le 2-N-(Boc)amino-4-(chlorométhyl)hexénoate a été utilisé dans les déplacements d'halogénures pour synthétiser la 4-vinylproline (4-Vyp), la 4-vinylornithine (4-Von) et le gamma-vinyl-alpha-amino-delta-lactamines. De plus, des azélates de diamines insaturées ont été utilisés pour synthétiser des dérivés d'acides aminés 6-hydroxyméthyle et 5- et 7-hydroxy indolizidine-2-one (I2aa) par des voies comportant une oxydation des oléfines. Des études par rayons X ont démontré que les résidus 6-hydroxyméthyle et 7-hydroxy I2aa peuvent imiter la géométrie du squelette des résidus centraux des tours beta de type II idéal. Le remplacement du résidu I2aa d'un puissant modulateur de la prostaglandine-F2α (récepteur PGF2alpha (FP) par les homologues substitués en position 5, 6 et 7 a été effectué pour étudier les influences des substituants et la géométrie du squelette sur les effets inhibiteurs sur la contractilité myométriale chez modèles de souris. Une passerelle prometteuse pour la préparation de différents acides aminés hétérocycliques a été ouverte en utilisant des acides aminés insaturés comme synthons de départ. Dans ces voies, l'oléfine a servi comme moyen d’élargir la diversité des groupes fonctionnels sur les systèmes cycliques. L'accès à une variété de systèmes cycliques substitués a élargi la boîte à outils pour étudier les structures peptidiques à l'aide d'acides aminés hétérocycliques substitués.